Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05235724 · ClinicalTrials.gov registry record
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)
A clinical trial, sponsored by Sanofi.
- Completed
- Registry status
- 18
- Enrollment target
NCT05235724 is a clinical trial that has completed, run by Sanofi. The registered enrollment target is 18 participants.
The verdict
NCT05235724 has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Primary objective: To explore and quantify the association between nighttime scratching and sleep patterns objectively in pediatric participants with moderate to severe atopic dermatitis (AD) using an innovative Emerald touchless sensor. Secondary objective: To evaluate the feasibility of using the Emerald touchless sensor in a pediatric clinical trial setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-02-17 |
| Est. Completion | 2023-01-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05235724
The ClinicalTrials.gov registry entry for NCT05235724 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05235724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05235724 about?
NCT05235724 is a clinical study titled "A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)". Primary objective: To explore and quantify the association between nighttime scratching and sleep patterns objectively in pediatric participants with moderate to severe atopic dermatitis (AD) using an innovative Emerald touchless sensor. Secondary objective: To evaluate the feasibility of using the...
What is the current status of trial NCT05235724?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2022-02-17. Estimated completion is 2023-01-11.
Who is sponsoring clinical trial NCT05235724?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.